Home
Conditions
Multiple Myeloma and Plasma Cell Neoplasm

Clinical trial condition

Multiple Myeloma and Plasma Cell Neoplasm

Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.

214 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma and Plasma Cell Neoplasm trial results

Completed

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

NCT00432458

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia

NCT00004181

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

NCT00005606

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00004165

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

NCT00006225

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Breast Cancer, +67 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004904

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00004902

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

NCT00281801

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Multiple Myeloma and Plasma Cell Neoplasm

Multiple Myeloma and Plasma Cell Neoplasm trial results

Related conditions